|
DPH3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.569160E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.568300E-04 |
| Normal-vs-Stage2 |
3.457400E-01 |
| Normal-vs-Stage3 |
3.838400E-04 |
| Normal-vs-Stage4 |
6.01020000434715E-08 |
| Stage1-vs-Stage2 |
2.432600E-01 |
| Stage1-vs-Stage3 |
5.031600E-01 |
| Stage1-vs-Stage4 |
4.679000E-03 |
| Stage2-vs-Stage3 |
1.417550E-01 |
| Stage2-vs-Stage4 |
2.498300E-02 |
| Stage3-vs-Stage4 |
1.487170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.609200E-04 |
| Normal-vs-AfricanAmerican |
4.3772000000164E-06 |
| Normal-vs-Asian |
1.33679999958503E-07 |
| Caucasian-vs-AfricanAmerican |
2.513200E-01 |
| Caucasian-vs-Asian |
1.906350E-02 |
| AfricanAmerican-vs-Asian |
2.119000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.241200E-03 |
| Normal-vs-Female |
1.412090E-04 |
| Male-vs-Female |
6.751200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.27300000002584E-06 |
| Normal-vs-Age(41-60Yrs) |
3.755400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.122300E-03 |
| Normal-vs-Age(81-100Yrs) |
9.199000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.327800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.254600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.313000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.976800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.276800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.272200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.987940E-02 |
| Classical-VS-Follicular |
2.093900E-02 |
| Classical-VS-Other |
3.202300E-02 |
| Classical-VS-Normal |
1.62564999999226E-05 |
| Tall-VS-Follicular |
3.597700E-03 |
| Tall-VS-Other |
5.157600E-01 |
| Tall-VS-Normal |
9.91159999630398E-08 |
| Follicular-VS-Other |
2.101200E-03 |
| Follicular-VS-Normal |
7.666400E-01 |
| Other-VS-Normal |
3.45719999961247E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.943200E-03 |
| Normal-vs-N1 |
3.63979999473685E-08 |
| N0-vs-N1 |
6.011800E-04 |
|
|
